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1. Introduction 
1.1 Background and history of bacterial artificial chromosome (BACs) 
BACs were first developed as a large insert cloning system to facilitate the construction of 
DNA libraries to analyze genomic structure (Shizuya, Birren et al. 1992). BACs are derived 
from a fertility plasmid (F-plasmid) found in the Escherichia coli. BACs can clone extremely 
large DNA molecules, ranging from 150-700kb,and averaging 350 kb. Another advantage of 
BACs over other cloning technologies is its stability in cell culture and ease of manipulation. 
Because some recombinant viruses were too large to be generated by traditional techniques, 
BAC technology was developed to carry out genetic and functional studies of viruses, 
especially herpesvirus. (Warden, Tang et al. 2011). From the time when BACs emerged a 
decade ago, their application have grown intensely and have benefited the research 
community in many fields, such as sequencing of the human genome, in vitro transgenesis, 
genomic fingerprinting, and even to vaccine development.  
1.2 BACs generation 
BACs can be considered as plasmid expression vectors, amplified in bacteria and composed 
of a small amount of bacterial DNA derived from the single copy F-plasmid (Shizuya, Birren 
et al. 1992). F-plasmid has genes required for prokaryotic replication, partition, and 
selection. Viral BACs are generated by inserting a BAC vector sequence into a viral genome 
(Warden, Tang et al. 2011). Direct deletion mutants and random transposon mutagenesis of 
viral BACs are commonly used to determine the function of viral genes (Warden, Tang et al. 
2011). Mammalian DNA, human genome or mouse genome (100–350 kb) can also be cloned 
as BACs vectors. Currently most regions of the human genome and the genome of other 
species are available as BACs. These vectors are useful tools in human genome-sequencing 
projects (Lander, Linton et al. 2001; Venter, Adams et al. 2001) and transgenic mice studies. 
Using endogenous homologous recombination systems in E. coli (Copeland, Jenkins et al. 
2001), BACs can be modified in many ways by recombination. They can be genetically 
engineered to express reporter genes, or to put a transgene under a specific promoter which 
will be more amenable in gene expression in the mammalian cells. BACs can be modified to 
replace any nucleotide sequence of interest (gene replacement), remove any existing DNA 
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sequence, or introduce new sequences without removing any of the existing sequences 
(gene removal or insertion). In addition BACs are also used to place nucleotide substitution 
through selection/counterselection strategy, and to conduct effective gap repair cloning of 
any target site of interest (Adamson, Jackson et al. 2011). 
1.3 Advantages and disadvantages of BACs 
Genes expressed from BACs mirror endogenous gene expression far more accurately than 
other cloning systems. The large size of BACs help to minimize site of integration effects, a 
phenomenon which has been defined as endogenous sequences (such as gene coding 
regions and distal regulatory elements) to be disrupted, and to produce potentially 
undesirable phenotypes (Adamson, Jackson et al. 2011) in gene cloning technology. The 
larger sized BAC constructs contain enhancers and locus control regions, which leads to 
more accurate gene expression in vivo (Townes, Lingrel et al. 1985; Jones, Monks et al. 1995). 
1995). The human genome BACs consist of the full gene structure, including untranslated 
regions, exons and introns, alternative promoters and splice sites and microRNA coding 
sequences. RNAs such as RNA splicing or microRNAs play very important role in gene 
regulation (Jackson and Standard 2007). Therefore the human genome BACs will ensure full 
mRNA processing and splicing when genes are transcribed, and produce the full 
complement of protein isoforms once mRNAs are translated. BACs can be transfected and 
expressed in mammalian cell lines although transfection efficiency and copy numbers are 
low (Magin-Lachmann, Kotzamanis et al. 2004; Sparwasser and Eberl 2007).  
BACs also have a number of disadvantages. A construct containing a large genomic 
fragment is likely to contain non-related genes that may lead to indirect, non-specific gene 
expression and unanticipated changes in the cell phenotype; Secondly, compared to 
plasmids or other gene expression vectors, the generation and screening of recombinant 
BAC constructs can be time-consuming and labor-intensive. Also, the oversized BAC DNA 
constructs are more easily sheared and degraded during manipulation before transfection; 
and some random recombination events may occur, for example, LoxP sites may lead to 
random Cre-mediated recombination (Semprini, Troup et al. 2007). Finally, repeating 
homologous sequences in some BACs constructs may undergo intramolecular 
rearrangements, which reduce the recombination efficiency and increase the rate of false-
positive clones in some selection/counter-selection approaches (Narayanan 2008). 
Overall, BACs have numerous advantages when compared to conventional plasmids. They 
protect the gene from site of integration effects and produce accurate regulation of 
transcription and translation. However, the large size results in technical difficulties when 
handling them as well as the potential non-specific gene expression. Therefore the 
application of BACs as a gene expression model system should be careful considered based 
on the pros and cons previously described.  
1.4 Application of BACs: Genomic sequencing, genomic imprinting, transgenic mice, 
vaccine development, and gene therapy 
There is increasing interest in the application of BAC technology in genomic research. High 
throughput determination of gains and losses of genetic material using high resolution BAC 
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arrays and comparative genomic hybridization (CGH) have been developed into the new 
tools for translational research in solid tumors and neurodegenerative disorders (Cowell 
and Nowak 2003; Cowell 2004; Costa, Meijer et al. 2008; Lu 2009). Among a large number of 
approaches for sequencing, BAC technology is becoming the most robust method for 
genome sequencing. The BAC-by-BAC technique uses an overlapping tilling path of large 
genomic fragments (150-200 kb) maintained within BACs. Every individual BAC is shotgun 
sequenced. Many short reads are assembled to produce the sequence of the BACs, where 
these large overlapping sequences of the BACs are assembled to produce the who genome 
sequence (Imelfort, Batley et al. 2009). BACs have also been used in mammalian genome 
mapping (Schalkwyk, Francis et al. 1995), genomic imprinting (Tunster, Van De Pette et al. 
2011), vaccine development and gene therapy (Magin-Lachmann, Kotzamanis et al. 2004; 
Warden, Tang et al. 2011). Studies of the evolutionary history and functional dynamics of 
sex chromosomes have recently been possible using BAC libraries (Janes, Valenzuela et al. 
2011). In this chapter we will review some applications of BACs in viral and non-viral gene 
functional studies. 
2. Viral gene functional studies 
2.1 Many human and animal herpesviruses genomes have been cloned as BACs 
Human herpesviruses are the second leading cause of human viral disease. Therefore the 
utilization of human herpesvirus BACs to study viral gene function (Warden, Tang et al. 
2011) has become more and more common. The herpesviruses are a family of DNA viruses 
which contain large and complex genomes. Genetic control and management of 
recombinant viruses have been notoriously difficult. The development of herpesvirus BACs 
have facilitated generation of recombinant viruses and subsequent studies of the biology 
and pathogenesis of herpesviruses (Knipe, Batterson et al. 1981; Zhou and Roizman 2005). 
Table 1 shows the human herpesviruses which have been cloned as BACs, including Herpes 
simples virus type 1 [(HSV-1 or human herpesvirus (HHV-1)], varicella-zoster virus (VZV or 
HHV-3), human cytomegalovirus (HCMV or HHV-5), Kaposi’s sarcoma-associated 
herpesvirus (KSHV or HHV-8) (Feederle, Bartlett et al. 2010; Warden, Tang et al. 2011). In 
general, BAC clones are relatively easy to make for alpha- and beta herpes viruses than 
gamma herpes viruses. This is due to the fact that DNA can only persistently stay in 
bacterial cells when it has a prokaryotic replicon. When a BACs flanked by specific 
Herpesvirus genomic sequences were introduced into infected cells to trigger homologous 
recombination. The great efficiency was achieved in alpha- and beta herpes viruses because 
lytic cellular systems are available, but was difficult for gamma herpesviruses (Delecluse, 
Hilsendegen et al. 1998; Delecluse, Kost et al. 2001; Zhou, Zhang et al. 2002; Kanda, Yajima 
et al. 2004; Chen, Li et al. 2007). In addition to BAC-based human herpesvirus studies, BAC-
based other animal herpesviruses are also currently available. These include murine 
cytomegalovirus 68 (MHV-68), murine gammaherpesvirus (mCMV), rhesus 
cytomegalovirus (rhCMV), rhesus rhadinovirus (RRV), pseudorabies virus (PrV), 
herpesvirus saimiri (HVS), Marek’s disease virus (MDV), bovine herpesvirus type 1 (BHV-
1), equine herpesvirus type 1 (EHV-1), feline herpesvirus (FHV-1), guinea pig 
cytomegalovirus (GPCMV), Koi herpesvirus (KHV) and turkery herpesvirus (HVT) 
(Feederle, Bartlett et al. 2010; Warden, Tang et al. 2011). 
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type synonym subfamily biological function and application reference 
HHV-1 
Herpes 
simplex 
virus-1 
(HSV-1) 
ǂ (Alpha) 
Generates a replication-proficient but 
packaging-deficient HSV-1 genome 
(152-kb HSV-1) for genetic 
manipulation as research tools or 
vectors in gene therapy. 
(Saeki, 
Ichikawa  
et al. 1998; 
Stavropoulos 
and Strathdee 
1998; 
Horsburgh, 
Hubinette  
et al. 1999) 
HHV-2 
Herpes 
simplex 
virus-2 
(HSV-2) 
ǂ 
Generates a recombinant HSV-2 BAC 
with the deletion of the HSV-2 
glycoprotein D (gD), elicites an HSV-2 
specific antibody response, serves as the 
basis for novel HSV-2 vaccine 
production. 
(Meseda, 
Schmeisser  
et al. 2004) 
HHV-3 
Varicella zoster virus 
(VZV) 
ǂ 
Human embryonic lung cells 
transfected with VZV BAC DNA show 
cytopathic effect, and viruses can 
spread to neighboring cells. 
(Nagaike, Mori 
et al. 2004) 
Luciferase VZV BAC generates 
recombinant VZV variants, eases 
subsequent viral growth kinetic 
analysis both in vitro MeWo cells and 
SCID-hu mice in vivo. 
(Zhang, Rowe  
et al. 2007) 
The mini-F transposition technique 
optimizes, repairs or restructures BACs, 
facilitates the development of gene 
therapy or vaccine vectors.  
(Wussow, 
Fickenscher  
et al. 2009) 
HHV-4 
Epstein-Barr 
virus (EBV), lymphoc
ryptovirus (LCV) 
Ǆ (Gamma)
Genetic analysis of all EBV functions, 
generation of attenuated EBV strains for 
vaccine design, development of viral 
vectors for human gene therapy. 
(Delecluse, 
Hilsendegen  
et al. 1998; 
Kanda, Yajima 
et al. 2004) 
Generates a self-recombining BAC 
containing 172-kb of the EBV genome; 
provides proof that EBNA-3B is not 
essential for EBV-mediated B-cell 
growth transformation in vitro. 
(Chen, 
Divisconte  
et al. 2005) 
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type synonym subfamily biological function and application reference 
HHV-5 
Cytomegalovirus 
(HCMV) 
ǃ (Beta) 
A new approach for construction of 
HCMV mutants. 
(Borst, Hahn  
et al. 1999) 
IE-2 (UL122) is required for successful 
HCMV infection and indicates that 
virus lacking IE-2 arrests early in the 
replication cycle. 
(Marchini, Liu  
et al. 2001) 
UL45 is dispensable for growth of 
HCMV in human fibroblasts and 
human endothelial cells 
(Hahn, Khan  
et al. 2002) 
A total of 252 ORFs with the potential 
to encode proteins have been identified 
in two laboratory strains (AD169 and 
Towne) and four clinical isolates 
Toledo, FIX, PH, and TR 
(Murphy, Yu  
et al. 2003) 
HCMV strain TB40/E is available as a 
BAC clone suitable for genetic 
engineering. 
(Sinzger, Hahn 
et al. 2008) 
Develops a “gene capture” method to 
rescue a large deletion mutant (15kb) of 
HCMV. 
(Dulal, Zhang  
et al. 2009) 
HHV-6 
Roseolovirus, 
Herpes 
lymphotropic 
virus 
ǃ 
Develops a single-step production of 
viral BACs by introducing the 160-kb 
human herpes virus 6A genome into 
BACs by digesting the viral DNA 
replicative intermediates with the Sfil 
enzyme that cleaves the viral genome in 
a single site 
(Borenstein 
and Frenkel 
2009) 
HHV-7 Roseolovirus ǃ  Not available 
HHV-8 KSHV Ǆ 
BAC KSHV can be efficiently shuttled 
between bacteria and mammalian cells, 
such as BCBL-1, 293, HeLa and E6E7-
immortalized human endothelial cells. 
(Delecluse, 
Kost et al. 
2001; Zhou, 
Zhang  
et al. 2002;  
Liu 2010) 
 
Table 1. List of available BACs for human HSV 
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2.2 vGPCR-mediated angiogenesis through activation of p38 and STAT3 in KSHV 
infected cells using KSHV BACs  
The molecular mechanism whereby viral G protein-coupled receptor (vGPCR) signaling 
regulates vascular endothelial growth factor (VEGF) expression in Kaposi sarcoma (KS) 
formation remains somewhat undefined. mECK36 cells, generated by transfection of mice 
bone marrow endothelial cells with KSHV bacterial artificial chromosome (KSHVBac36), have 
been reported to be angiogenic, tumorigenic, and suitable for demonstrating a nonredundant 
role for vGPCR in KSHV-mediated tumorigenesis (Mutlu, Cavallin et al. 2007). In our previous 
report (Liu 2010), we utilized mECK36, the cells composed of wild-type KSHVBac36 or the 
cells without vGPCR, namely vGPCR-null KSHVBac36 mutant, to dissect the molecular 
mechanisms of VEGF secretion induced by vGPCR in the context of KSHV infection. The mice 
bone marrow endothelial cells (mEC) were obtained from Balb/C An Ncr-nu mice (NCI, 
Bethesda, MD) bone marrow. Mice femurs were flushed twice with phosphate-buffered saline 
(PBS), and the elutes were incubated in Dulbecco’s modified Eagle’s medium (DMEM) media 
plus 30% fetal borine serum (FBS) (Gemini Bioproducts, Calabasas, CA), endothelial growth 
factor (EGF) 0.2 mg/mL (Sigma, St. Louis, MO), endothelial cell growth factor supplement 
(ECGS) 0.2 mg/mL (Sigma), heparin 1.2 mg/L (Sigma), insulin transferrine selenium 
(Invitrogen, Carlsbad, CA), penicilin-streptomicin 1% (Invitrogen), and BME vitamin (VWR 
Scientific, Rochester, NY). KSHVBac36 was constructed by inserting a full-length recombinant 
KSHV genome into a bacterial artificial chromosome, KSHVBac36 was transfected into mEC 
cells to generate mECK36 cells using lipofectamine 2000 (Invitrogen) and selected with 
hygromycin-B. The cells were then grown in the absence of hygromycin to negatively select 
cells and therefore generate mECK36-KSHV-Null cells, which lost the KSHV episome (KSHV 
episome was measured by GFP marker). Next, KSHVBac36 construct was retransfected into 
mECK36-KSHV-Null cells to generate BBac36. Finally, the genotypic markers of vGPCR were 
knocked out from KSHVBac36 by transposon mutagenesis to generate ORF74/vGPCR 
deletion mutant and stably transfected into mECK36-KSHV-Null cells to create BΔvGPCR cells 
in the presence of hygromycin selection. We found (Liu 2010) that vGPCR activates VEGF 
transcription via p38 MAPK and STAT3 in mECK36 and mECK36-derived cell models. In 
addition, we also found that in cells containing KSHV genome, STAT3 is tyrosine-
phosphorylated and translocated into the nucleus, transactivating the target VEGF gene by 
binding to the specific DNA element TT (N4–5) AA in a vGPCR-dependent manner. 
Moreover, treatment of mECK36-derived cells with AG490 or a dominant negative STAT3 
DNA vector showed strong inhibitory effects on vGPCR-induced VEGF promoter activity. In 
addition, vGPCR can up-regulate STAT3 mRNA levels. Together, our findings show that 
vGPCR plays a nonredundant role in STAT3 activation in KSHV infected cells, and this 
activation plays an important role in the connection of the viral oncogene vGPCR and VEGF 
up-regulation. Our results indicate that vGPCR has a broad signaling activating capacity in the 
context of KSHV infection and suggest that the STAT3 pathway could be a good target for 
preventing KSHV-mediated angiogenesis in KS.  
2.3 Genetic determinants of virus tropism genes using BACs 
Many cell types, including endothelial cells (ECs), myeloid lineage cells, and smooth muscle 
cells are permissive cells for HCMV persistent replication and latency (Jarvis and Nelson 2007). 
During acute infection of CMV in immune-compromised patients, a number of cell types, such 
as ECs, various leukocytes, epithelial cells, hepatocytes, smooth muscle cells, and fibroblasts, 
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can be infected because of uncontrolled replication of viruses (Howell, Miller et al. 1979; 
Myerson, Hackman et al. 1984; Gnann, Ahlmen et al. 1988; Wiley and Nelson 1988; Dankner, 
McCutchan et al. 1990; Sinzger, Grefte et al. 1995; Read, Zhang et al. 1999; Bissinger, Sinzger et 
al. 2002). ECs appear to play a critical role in the process of HCMV persistent active infection 
and maintenance within the host, which is controlled by genetic determinants. Previous 
studies observed that HCMV strains differed in their ability to infect ECs, which are called EC 
tropism (MacCormac and Grundy 1999; Sinzger, Schmidt et al. 1999; Kahl, Siegel-Axel et al. 
2000). The research on EC tropism has been strengthened by the availability of genetically 
stable CMV BACs and subsequent mutagenesis of these BACs (Brune, Menard et al. 2001; 
Scrivano, Sinzger et al. 2011). The switch of cell tropism in different cell types after alternate 
replication might direct infection from one cell type to the other. 
The typical model for tropism is the difference in cell tropism of virus released from EC and 
fibroblasts. Supernatants from infected human foreskin fibroblasts (HFF) showed a higher 
ability to infect EC than EC-derived supernatants (Scrivano, Sinzger et al. 2011). Scrivano et al 
(Scrivano, Sinzger et al. 2011) using mutagenesis of the BAC-cloned HCMV strain TB40/E 
(TB40-BAC4) found that ECs release a virus progeny of unEC-tropic (not EC-tropic), and retain 
a progeny of highly EC-tropic; while HFF release both EC-tropic and non EC-tropic virus 
progeny, HFF progeny is composed of both EC-tropic and non EC-tropic virus populations. 
The biochemical basis for this phenomenon is due to a different level of 
gH/gL/pUL(128,130,131A) complex in virions (Scrivano, Sinzger et al. 2011). The CMV EC 
tropism has been characterized by a “genomic tropism island” composed of three open 
reading frames (ORFs): UL128, UL130, and UL131A. The region of these genes is important for 
EC tropism (Hahn, Revello et al. 2004; Scrivano, Sinzger et al. 2011). EC-tropic population most 
likely is a population with a high gH/gL/pUL(128,130,131A) content. UL128, UL130, and 
UL131A are required for replication of HCMV in HUVECs (Hahn, Revello et al. 2004). EC 
tropism for HCMV is highly dependent on the roles of pUL128, pUL130, and pUL131A 
(Jarvis and Nelson 2007) in virions. EC-tropism produced by an EC-tropic progeny released 
by HFF, can be depleted with antibodies directed against pUL131A. They propose that the 
difference in cell tropism of virus released from EC and fibroblasts is caused by a sorting 
process. EC strongly and specifically retain EC-tropic viruses through the 
gH/gL/pUL(128,130,131A) complex. Thus, the levels of gH/gL/pUL(128,130,131A) 
complexes could define whether a particle is EC-tropic or not. A disulfide-linked complex 
between gH/gL glycoproteins is required for viral entry and fusion. The gH/gL exists in 
two distinct forms, one composed of pUL128, pUL130, and pUL131A. The pUL128 and 
pUL130 proteins are linked with gH/gL; pUL131A is required for infection of ECs. The 
second distinct form is composed of gO alone; the gO protein is linked with gH/gL and is 
required for replication in fibroblasts. The gH/gL/pUL128/pUL130/pUL131A unit in 
virions is mandatory for access into ECs which are pH-dependent. Whereas the gH/gL/gO 
unit in virions are mandatory for access into fibroblasts which are also pH-independent 
(Jarvis and Nelson 2007). Recently, results from Wang et al showed (Wang, Yu et al. 2007) 
that HCMV progenies derived from epithelial cells and fibroblasts are also different. It 
seems the propensity of cells to release viruses plays a crucial role in the establishment of 
infection and transfer of viruses to new hosts or the fetus.  
In addition to HCMV, EBV also works as a cell type-tropic virus. Hutt-Fletcher et al (Hutt-
Fletcher 2007) has established the paradigm that epithelial cells produce a EBV virus 
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progeny with high levels of gH/gL/gp42 complexes, facilitating B-cell infection. B-cells in 
turn, generate virus progeny with low levels of gH/gL/gp42 complexes which efficiently 
infect epithelial cells, but not B cells. To some extent, this relative switch of cell tropism after 
alternate replication in epithelial and B-cells directs infection from one cell type to the other. 
2.4 Study of the immune response against the EBV using EBV BACs  
There are three recombinant wild-type EBVs that have been generated so far (Delecluse, 
Hilsendegen et al. 1998; Kanda, Yajima et al. 2004; Chen, Divisconte et al. 2005). They were 
generated by the insertion of the prokaryotic F-plasmid (F-factor) in two B95.8 or one Akata 
strains. Although the insertion sites differ in these three EBV BACs, at the site of the B95.8 
deletion (Delecluse, Hilsendegen et al. 1998), or at the major internal repeat region of the 
B95.5 strain (Chen, Divisconte et al. 2005), or at BXLF1 open reading frame (ORF) in Akata 
strain (Kanda, Yajima et al. 2004), the insertion site of the F-plasmid does not affect the 
phenotype of the virus. 
2.4.1 EBV infection 
EBV is tightly related to the development of many human cancers. Chen et al (Chen, 
Divisconte et al. 2005) has developed a BAC-GFP-EBV (containing 172-kb of the EBV 
genome) system to monitor early cellular and viral events associated with EBV infection. 
BAC-GFP-EBV was transfected into the HEK 293T epithelial cell line (Halder, Murakami et 
al. 2009). Then the progeny virus produced by a chemical was used to immortalize human 
primary B-cell which can be easily monitored by green fluorescence and proliferation. The 
results showed a dramatic increase in Ki-67, CD40, and CD23 signals. The viral genes 
express a pattern of an early burst of lytic gene expression. This up-regulation of lytic gene 
expression prior to latent genes during early infection strongly suggests that the resulting 
progeny virus is capable of infecting new primary B-cells (Halder, Murakami et al. 2009). 
This process may be critical for establishment of latency prior to cellular transformation 
(Halder, Murakami et al. 2009).  
2.4.2 EBV transformation  
EBV is associated with a number of human malignancies. There is increasing research 
interest in the molecular functions of these EBV gene products in transformation and 
evasion from host immune surveillance systems (Izumi 2001). BAC technology made the 
study on the molecular function of EBV transforming genes feasible because some latent 
genes such as EBNA1 cannot be maintained in latently infected B cells using traditional 
cosmid technology (Izumi 2001; Feederle, Bartlett et al. 2010). EBNA1 was found to function 
as a transactivator of other latent proteins, and was required for replication of the viral 
genome (Altmann, Pich et al. 2006). When 71kb of EBV DNA genome was amplified in E.coli 
and transfected into primary B-lymphocyes, Altmann et al (Altmann, Pich et al. 2006) 
identified that EBV DNA is sufficient to immortalize primary human B lymphocytes. 
Kempkes et al (Kempkes, Pich et al. 1995; Izumi 2001) also identified EBNA3a as a 
transforming gene, which contributes primarily to the initiation of cell proliferation 
(Kempkes, Pich et al. 1995; Izumi 2001). Two genes BALF1 and BHRF1 which encode 
homologous cellular antiapoptotic viral Bcl-2 proteins (vBcl-2), were suggested to interfere 
with the cell apoptosis program to counteract cell death, which protects the virus from 
apoptosis in its host cell during virus synthesis (Altmann and Hammerschmidt 2005). 
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2.4.3 Immune evasion 
Several viral proteins have been found to block immune recognition of viral proteins as 
antigens during lytic replication, such as BGLF5, BZLF2, BILF1 and BNLF2a (Ressing, van 
Leeuwen et al. 2005; Rowe, Glaunsinger et al. 2007; Zuo, Thomas et al. 2008; Croft, 
Shannon-Lowe et al. 2009; Zuo, Currin et al. 2009; Zuo, Quinn et al. 2011). The direct 
contribution of BNFL2a in immune evasion was evidenced using an EBV BAC which 
initially disrupted the BNLF2a gene of the B95.8 strain by insertional mutagenesis (Croft, 
Shannon-Lowe et al. 2009). BNLF2 inhibits transporter associated with antigen (TAP). It 
encodes a 60 amino acid protein which prevents both peptide- and ATP-binding to TAP 
complex (Hislop, Ressing et al. 2007). Consequently, when co-expressed with target-
antigens, cells expressing BNLF2a show decreased levels of surface human leukocyte 
antigen (HLA)-class I and are resistant to CD8+ cytotoxic T cell killing (Hislop, Ressing et 
al. 2007). Croft et al (Croft, Shannon-Lowe et al. 2009) created a targeting plasmid with 
BNLF2a gene which was replaced by tetracycline resistant cassette. This plasmid was then 
flanked by FLP recombinase target (FRT) sites. This vector was homologously recombined 
with the EBV BAC, and designated as ∆DBNLF2a, which had the tetracycline gene 
removed by FLP recombinase. ∆DBNLF2a BACs were then stably transduced into 293 
cells, virus replication induced by transfection of a plasmid encoding the EBV lytic switch 
protein BZLF1 (Feederle, Kost et al. 2000). Compared to wild-type EBV BAC, this 
recombinant virus induces a strong MHC I T cell response against viral lytic genes than 
the wild type viruses (Feederle, Bartlett et al. 2010). Overall, these results indicate that 
BNLF2 prevents the immediate early and early proteins from being efficiently processed 
and presented to CD8 + T cells during lytic cycle replication. Contrary to BNLF2a in early 
evasion mechanism in the lytic cycle of EBV, other mechanism seems to operate later 
during immune evasion (Croft, Shannon-Lowe et al. 2009). Such stage-specific expression 
of immune evasion genes are a feature of several herpesviruses, such as CMV (Croft, 
Shannon-Lowe et al. 2009). Taken together, BNLF2a acts in concert with other immune-
evasion genes encoded by EBV T-cell surveillance (Croft, Shannon-Lowe et al. 2009). 
3. Non-viral gene functional studies 
3.1 Translational research by the analysis of entire cancer genomes using BAC arrays 
The development of high-resolution microarray-based comparative genomic hybridization 
(aCGH) using cDNA of BACs makes it possible for translational research to analyze the 
entire cancer genome in a single experiment. Well-designed aCGH studies will increase our 
understanding of the genetic basis of cancer, help to identify novel predictive and 
prognostic biomarkers for cancer, and molecular therapeutic targets in cancer. Compared to 
oligonucleotide arrays, BAC arrays have some specific features. BACs have been widely 
used in aCGH studies (Pinkel and Albertson 2005; Lockwood, Chari et al. 2006; Ylstra, van 
den Ijssel et al. 2006). The vast majority of array CGH data available today has been 
generated using BAC CGH arrays. BACs probes vary in length from 150 to 200 kb (Pinkel 
and Albertson 2005). The probe of genome-wide BAC arrays range from 2,400 to 32, 000 
unique elements in tiling path array, where each BAC overlaps with its contiguous BACs. 
The resolution (the distance between each DNA target represented on the array) of each 
BAC array is defined by the number of unique probes it contains (Tan, Lambros et al. 2007). 
BAC tiling path arrays provide a resolution of up to 50 kb (Tan, Lambros et al. 2007). The 
development of a whole-genome BAC tiling path approach has improved resolution of CGH 
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by using overlapping clones (Ishkanian, Malloff et al. 2004; Lockwood, Chari et al. 2006). 
These platforms provide sufficiently strong signals to detect single-copy change, and are 
able to accurately define the boundaries of genomic aberrations, which can possibly be 
utilized in archival formalin-fixed, paraffin-embedded (FFPE) tissue (Johnson, Hamoudi et 
al. 2006; Little, Vuononvirta et al. 2006).  
High amounts of high-quality BAC DNA are needed to obtain good array performance 
(Ylstra, van den Ijssel et al. 2006). BACs DNA yield is generally low when isolated from 
E. coli (Pinkel and Albertson 2005). Because of the low yields of DNA from isolated BAC 
clones, DNA amplification is required to generate sufficient quantities of adequately 
pure BAC DNA for the assay. Therefore a tiling path array is costly and highly labor 
intensive. In addition, as BAC probes are representative of the human genome, they also 
contain repetitive sequences, which can result in nonspecific hybridization (Tan, 
Lambros et al. 2007).  
3.2 Measurement of neuroblastoma DNA copy number aberrations (CNAs) 
BAC technique has increasing been applied in detecting structural changes in chromosomes, 
such as copy number aberrations (CANs) and rearrangement. Mosse et al (Mosse, Greshock et 
al. 2005) generated 4135 BAC clones spanning the human genome at about 1.0 Mb resolution 
as targets for array-based comparative genomic hybridization (aCGH) experiments (Greshock, 
Naylor et al. 2004). They measured the relevance of neuroblastoma DNA copy number 
changes (CNAs) in forty-two human neuroblastoma cell lines. They found that all cell lines 
exhibited CNAs ranging from 2% to 41% of the genome. Chromosome 17 showed the highest 
frequency of CANs. The most frequent region of gain with high-level amplification localized 
to 2p24.22-2p24.3 detected in 81% of cell lines (Mosse, Greshock et al. 2005). Potential 
oncogenes such as MYCN, NAG and DDX1 were located in these regions. The less frequent 
region of gain localized to 17q23.2, 17q23.3-17q24.1, 17q24.1-17q24.2, 17q25.2-17q25.3 was 
detected in about 70% of the cell lines. Potential oncogene BIRC5 was localized in these 
regions. Although gain of 17q material was common, this low level gain of chromosomal 
material was rather complicated (Mosse, Greshock et al. 2005). The most frequent hemizygous 
deletion localized to a 4.0 Mb region at 1p36.23-36.32, was detected in 60% of the cell lines. 
Potential tumor suppressor genes TP73, CHD5, RPL22 and HKR3 were also localized. A 10.4 
Mb region at 11q23.3-11q25 was detected in 36% of the cell lines, and the potential tumor 
suppressor gene CHEK1 was found there as well (Mosse, Greshock et al. 2005). Overall, the 
array CGH could be reliable in examining DNA copy number aberrations including single 
copy gain or loss. Compared to the data with standard techniques, data from array CGH 
correlates well with known aberrations detected by standard techniques. Therefore, array 
CGH can be applied to identify novel regions of genomic imbalance.  
3.3 Fluorescence in situ hybridization (FISH) analysis of pathological archives with 
BACs 
It is now known that there are extensive somatic changes, including multiple point 
mutations (Wood, Parsons et al. 2007; Velculescu 2008), copy number alterations (Weir, Woo 
et al. 2007; Kubo, Kuroda et al. 2009), and further complex rearrangements (Campbell, 
Stephens et al. 2008) tumors. But when and where these genetic changes occur during 
human cancer development remains unclear. Human archival tissue blocks contain 
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specimens of human tumors in various stages of development, which are precious in the 
post-human-genome-sequencing era. Based on their findings and other’s work, Sugimura et 
al (Sugimura, Mori et al. 2010) stated that the intensive application BAC clones as probes for 
FISH that have exact ‘addresses’ in the whole genome will become a useful diagnostic tools 
for pathologists. Thousands of BAC clones are commercially available, and any of them can 
be used as FISH probes. Sugimura et al tested 100 BAC probes containing different kinase 
loci in a gastric, colorectal, and lung cancer detection sets (20 cases for each organ) by using 
tissue microarray (TMA)-FISH technology (Sugimura, Mori et al. 2010). Sugimura et al 
found that unexpected kinase loci were amplified in a significant proportion of human 
common solid tumors (Sugimura, Mori et al. 2010). Combinatory chemistry has generated 
many drugs by targeting kinase genes or their products. Thus, amplification of specific 
regions on certain kinase genes are amenable to pharmacological intervention which could 
result in the target specific therapy. Therefore it is reasonable to believe that the FISH-BACs 
diagnostic system combined with particular kinase probes may provide the practical basis of 
individual cancer therapy. 
3.4 Interferon-γ locus regulation with BACs 
To investigate the regulatory properties of conserved non-coding sequence (CNS) element 
of interferon-Ǆ (Ifng) gene in vivo, Hatton et al (Hatton, Harrington et al. 2006) developed a 
BAC-based transgenic reporter system to express Ifng gene expression. They introduced a 
Thy1.1 reporter into exon 1 of Ifng and placed this reporter into a BAC containing 
approximately 60 kb upstream of exon 1 of ifng and approximately 100 kb downstream of 
exon 4 of ifng sequences. The CNS-22 region of BAC was then flanked with loxP sites 
(Hatton, Harrington et al. 2006; Wilson and Schoenborn 2006). Because activation of the 
large BAC transgenic allele unlikely perturbs endogenous alleles (Valjent, Bertran-Gonzalez 
et al. 2009), potential confounding effects of altered IFNg production were possibly 
eliminated (Hatton, Harrington et al. 2006). Hatton et al chose Thy1.1 (CD90.1) as a reporter 
because of its low immunogenicity and easy detection in the context of CD90.2 allotype of 
the C57BL/6 background. The recombined BACs (Ifng-Thy1.1 BAC) containing the Thy1.1 
reporter and floxed CNS-22 were microinjected into fertilized C57BL/6 oocytes (Hatton, 
Harrington et al. 2006; Wilson and Schoenborn 2006). As a result, the Ifng-Thy1.1 BAC-in 
transgene completely mirrored endogenous Ifng gene expression; and conditional deletion 
of the CNS-22 element from the single copy transgene by Cre recombinase resulted in 
almost complete loss of Thy1.1 expression in Th1 cells, CD8+ T cells, and NK cells 
irrespective of activation through the T cell receptor (TCR)-dependent or TCR-independent 
pathways. Thus, CNS-22 is considered to be critically involved in Ifng gene expression, 
irrespective of adaptive or innate immune cell lineage (Hatton, Harrington et al. 2006; 
Wilson and Schoenborn 2006). CNS-22 functions as an enhancer both in vitro and in vivo, 
which will shed new light on ifng regulation and open up avenues for future investigation. 
3.5 Studies of Kras-mediated pancreatic tumorigenesis with BACs 
Activation of Kras gene by mutation plays a critical role in human pancreatic cancer 
(Almoguera, Shibata et al. 1988; Shibata, Almoguera et al. 1990). Although the known 
capability of oncogenic Kras to function as a key initiator of pancreatic malignancy, the 
mechanism(s) of Kras-caused initiating events are still unclear. This is an important reason 
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why prognosis for patients with malignant pancreatic tumors have not entirely improved 
over the past twenty years (Jemal, Siegel et al. 2006). Moore et al have discovered that the 
zebrafish develop pancreatic cancer after exposure to chemical mutagens (Moore, Rush et al. 
2006). The studies have also shown that mammalian and zebrafish pancreas are significantly 
similar in anatomy and histology (Wallace and Pack 2003; Chen, Li et al. 2007). Therefore, 
the Zebrafish has emerged as an experimental model for study of human pancreatic cancer 
biology (Davison, Woo Park et al. 2008; Park, Davison et al. 2008). Another benefits of 
working with zebrafish model is their translucency, which greatly improves the 
visualization of fluorescent trangenes in both embryos and adult zebrafish (Davison, Woo 
Park et al. 2008). Park et al (Park, Davison et al. 2008) discovered that oncogenic Kras causes 
pancreatic cell expansion and malignant transformation in the zebrafish exocrine pancreas 
by utilizing eGFP-Kras BAC transgenes (160kb) under the regulation of Ptf1a regulatory 
elements. Ptf1a induces differentiation, growth and proliferation of pancreatic progenitor 
cells (Park, Davison et al. 2008). Briefly, they expressed either extended green fluorescent 
protein (eGFP) alone or eGFP fused to oncogenic Kras in developing zebrafish pancreas and 
continuously detected the expression of fluorescent transgenes transcutaneously during all 
stages of development including the adult zebrafish. They first generated polymerase chain 
reaction (PCR) products encoding the eGFP and eGFP-Kras transgenes flanked by sequences 
homologous to the CH211-142 BAC that spans the Pfta1 gene locus. Homologous 
recombination leads to accurate replacement of the Ptf1a coding sequences with the eGFP 
and eGFP-Kras transgene (Davison, Woo Park et al. 2008). Their results demonstrate that 
oncogenic Kras-expressed pancreatic progenitor cells fail to undergo characteristic exocrine 
differentiation although their initial specification and migration are observed to be normal 
(Davison, Woo Park et al. 2008; Park, Davison et al. 2008). Blocks of differentiation leads to 
abnormal accumulation of the undifferentiated progenitor cells, correlates with the 
formation of invasive pancreatic cancer. Besides similarity in anatomy and histology, 
Zebrafish pancreatic tumors share several activated signaling pathways with the human 
pancreatic tumors, including activation of ERK and AKTby phosphorylation, as well as 
abnormal Hedgehog pathway activation which was justified by the up-regulation of ptc1 
mRNA and gli1 mRNA (Park, Davison et al. 2008). These findings provide a unique view of 
the tumor-initiating effects of oncogenic Kras in a living vertebrate organism, but more 
important it suggest that BACs transgene targeting other oncogenes or tumor suppressor 
genes in zebrafish pancreatic cancer may improve our understanding of the human disease. 
3.6 Studies on striatal signaling pathways in central nervous system (CNS) with BACs 
To understand the role of molecular signaling pathways involved in behavioral responses, it 
is necessary to delineate the molecular events that take place in neurons. This task has been 
hampered by the complexity of neuronal system. There are hundreds of distinct neuronal 
populations and these populations are very difficult to distinguish (Valjent, Bertran-
Gonzalez et al. 2009). The development of BAC transgenic mice expressing various 
reporters, epitope tagged-proteins or Cre recombinase driven by specific promoters, greatly 
facilitates the research in this field. Generally speaking, transgene expression is influenced 
by copy numbers and site of insertions (positional effects). Large BAC transgenes (BACs 
contain large fragments 150-200kb of mouse genome) have usually a low copy number, are 
less likely influenced by positional effects, and are able to recapitulate the regulation of 
endogenous genes much better than shorter transgenes (Yang, Model et al. 1997). Over the 
past few years, the use of BAC EGFP transgenic mice have generated significant 
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development in the analysis of striatal physiology and physiopathology (Valjent, Bertran-
Gonzalez et al. 2009). The drd1a-EGFP (EGFP reporter is driven by dopamine D1 receptor-
D1R promoter), drd2-EGFP (EGFP reporter is driven by dopamine D2 receptor-D2R 
promoter) and chrm4-EGFP (EGFP reporter is driven by cholinergic receptor, muscarinic 4- 
CHRM4 receptor promoter) BAC transgenic mice have been extensively utilized to 
investigate the physiological features of striatonigral and striatopallidal medium spiny 
projection neurons (MSNs) (Lobo, Karsten et al. 2006; Kreitzer and Malenka 2007; Cepeda, 
Andre et al. 2008; Gertler, Chan et al. 2008). Among these major findings are as follows: 
1)D1R-expressing MSNs are less excitable than D2R–MSNs (Lobo, Karsten et al. 2006; 
Kreitzer and Malenka 2007; Cepeda, Andre et al. 2008; Gertler, Chan et al. 2008) due to 
different morphology (Gertler, Chan et al. 2008), and some presynaptic factors (Kreitzer and 
Malenka 2007; Cepeda, Andre et al. 2008). Corticostriatal synapses are activated by 
repetitive stimulation; in contrast, thalamostriatal synapses are inhibited by repetitive 
stimulation (Ding, Peterson et al. 2008); 2) D1R-expressing MSNs collaterals are functionally 
connected primarily with other D1R–MSNs, whereas D2R-expressing neurons collaterals are 
connected with both D2R– and D1R–MSNs (Taverna, Ilijic et al. 2008). D2R–MSNs synapse with 
GABAA receptors are stronger (Taverna, Ilijic et al. 2008) and generate greater GABAA 
receptor-mediated tonic currents (Ade, Janssen et al. 2008) than D1R–MSNs (Janssen, Ade et al. 
2009); 3)The single back-propagating action potentials invade more distal dendritic regions in 
D2R–than in D1R–MSNs, due to a difference in voltage-dependent Na+channels and Kv4 K+ 
channels (Day, Wokosin et al. 2008); 4) In the dopamine-depleted striatum, the corticostriatal 
connections are decreased in D2R neurons (Day, Wang et al. 2006), whereas dendritic 
excitability is increased in this region (Day, Wokosin et al. 2008; Taverna, Ilijic et al. 2008).  
4. Conclusions and overall perspectives  
Studies on BACs have demonstrated their importance in many research fields, from 
microbiology, virology, to human genetics, neuroscience, and proteomics (Narayanan 2008; 
Adamson, Jackson et al. 2011). The power to clone and handle large sized intact genome 
with high fidelity by BAC has enabled scientists to design and perform both mechanistic 
and functional studies in an ever expanding field. 
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6. Glossary  
aCGH: array-based comparative genomic hybridization  
BACs: bacterial artificial chromosome 
BHV-1: bovine herpesvirus Type 1  
CGH: comparative genomic hybridization 
CHRM4: cholinergic receptor, muscarinic 4- receptor 
CMV: cytomegalovirus  
CNAs: copy number changes 
CNS: central nervous system  
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D1R: dopamine D1 receptor 
D2R: dopamine D2 receptor 
ECs: endothelial cells  
eGFP: extended green fluorescent protein 
EHV-1: Equine herpesvirus Type 1  
FFPE: archival formalin-fixed, paraffin-embedded 
FHV-1: Feline herpesvirus  
FISH: fluorescence in situ hybridization  
F-plasmid: a fertility plasmid  
GPCMV: Guinea pig cytomegalovirus 
HCMV or HHV-5: human cytomegalovirus  
HFF: human foreskin fibroblasts  
HLA: human leukocyte antigen 
HSV-1: Herpes simples virus type 1  
HSV-2: Herpes simples virus type 2  
HUVECs: human umbilical vein endothelial cells 
HVS: herpesvirus saimiri  
HVT: Turkery herpesvirus  
HPV: herpesviruses 
Ifng: interferon-Ǆ  
KHV: Koi herpesvirus  
KSHV or HHV-8: Kaposi’s sarcoma-associated herpesvirus,  
LCV: lymphocryptovirus 
MDV: Marek’s disease virus 
mECK36 cells: mouse bone marrow endothelial cells generated by transfection of with 
KSHVBac36 
MSNs: medium spiny projection neurons 
VEGF: vascular endothelial growth factor  
vGPCR: viral G protein-coupled receptor  
VZV or HHV-3: varicella-zoster virus,  
KSHVBac36: KSHV bacterial artificial chromosome, 
mCMV: murine gammaherpesvirus  
MHV-68: Murine cytomegalovirus 68  
ORFs: open reading frames  
PCR: polymerase chain reaction 
PrV: pseudorabies virus  
rhCMV: Rhesus cytomegalovirus  
RRV: rhesus rhadinovirus  
TMA: tissue microarray  
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